Administered activity | Largest radiation dose | Effective dose | Effective dose | ||||||||
Radiopharmaceutical | MBq | mCi | Organ | mGy/MBq | rad/mCi | mGy | rad | mSv/MBq | rem/mCi | mSv | rem |
99mTc-pertechnetate*(no blocking agent) | 75–150 intravenously | 2–4 | Upper large intestine | 0.057 | 0.21 | 4.3–8.6 | 0.43–0.86 | 0.013 | 0.048 | 0.98–2.0 | 0.098–0.2 |
99mTc-sestamibi (rest)* | 185–925 intravenously | 5–25 | Gallbladder | 0.039 | 0.14 | 7.2–36 | 0.72–3.6 | 0.009 | 0.033 | 1.6–8.3 | 0.16–0.83 |
99mTc-tetrofosmin (rest)† | 185–925 intravenously | 5–25 | Gallbladder | 0.027 | 0.10 | 5.0–25 | 0.5–2.5 | 0.0069 | 0.026 | 1.3–6.4 | 0.13–0.64 |
123I-iodide (assuming 35% uptake)‡ | 7.5–20 by mouth | 0.2–0.6 | Thyroid | 4.5 | 17 | 34–90 | 3.4–9.0 | 0.22 | 0.81 | 1.6–4.4 | 0.16–0.44 |